From RNS17 Jun 2021 12:38
FINANCIAL RESULTS
As the Chairman has noted, Group sales for the 12 months ended 31 December 2020 (prior period: 13 months ended 31 December 2019) more than doubled to £1,523,247 (2019: £744,883). This 104% increase in revenues would have +placed OptiBiotix Health among the top ten growth companies in the UK during 2020 (The UK's Top Ten Fastest Growing Companies Revealed, Forbes August 2020).